Current location - Trademark Inquiry Complete Network - Trademark inquiry - Are Revision Pharmaceutical and Revision Fruit the same company?
Are Revision Pharmaceutical and Revision Fruit the same company?
Belonging to a company, Qingguo is a subsidiary of Xiuzheng Pharmaceutical.

Revision Pharmaceutical Group is a large modern private enterprise integrating scientific research, production and marketing. Its headquarters is in Changchun and its marketing headquarters is in Beijing. The industrial layout extends from Tonghua, a famous medical city, to Liuhe, Shuangyang, Changchun, Beijing, Sichuan, Nanchang and other places. The total floor area is117000m2, and the total construction area is 390000m2. The group has 18 wholly-owned subsidiaries with more than 20,000 employees and total assets of 2.5 billion yuan.

First, corporate culture

The corporate culture of the group takes "benevolence, righteousness, courtesy, wisdom and trust" as the core, integrates modern management concepts, and then permeates all positions through the spirit of enterprise, practicing "correcting while growing, and growing while correcting", which greatly improves the cohesion of the enterprise, enhances the sense of historical mission and social responsibility of employees, and realizes the overall improvement of employees' quality. In 2003, Revision Pharmaceutical Group "China Growth Enterprise Revision Organization" won the China Corporate Culture Innovation Award. In 2004, the revised organization "New Confucianism of Oriental Enterprises" put forward the neo-Confucian life ideal of "self-cultivation, keeping the family in order, strengthening the enterprise and enriching the country" and the modern oriental enterprise culture of "benevolence, innovation, benefit, wisdom and trust", and was awarded to China. Chairman Xiu Laigui won the Innovation Award of Corporate Culture Management in China and the Founder Award of Corporate Philosophy in China.

Second, products and services

The group can produce more than 400 kinds of products in 17 dosage form. Guided by four famous brands: Starshu Capsule, Yiqi Yangxue Oral Liquid, Naoxinshu Oral Liquid and Xiaomi Suppository, a large number of leading products such as Ning Fei, Ge Ping and Gugufengtong Tablet won the national gold medal and excellent product award, becoming well-known brands at home and abroad. Among them, "Xingshu" was recognized by the State Administration for Industry and Commerce as the first "China Famous Trademark" in the domestic stomach medicine market, and it has been in a leading position in the national stomach medicine market.

The Group has national enterprise technology centers and branches in Shenyang and Shanghai. At present, there are more than 300 famous medical experts and researchers at home and abroad, and they have all cooperated and exchanged with universities and research institutes at home and abroad. New drug research and development should realize production generation, research and development generation and reserve generation.

Taking the road of modernization of traditional Chinese medicine, the Group pursues collectivized management and large-scale development, forming a development pattern of "one national enterprise technology center, six preparation bases, four raw material bases and ten sales platforms" and maintaining a strong development trend.

The Group has established a nationwide marketing network, 38 provincial branches (2 large provincial branches) and 466 prefecture-level offices, which have obvious characteristics and outstanding performance in the market competition.

The group has changed from seeking survival and development to pursuing the consistency of corporate interests and social interests. It is used for various donations and investment in glorious undertakings, with a cumulative value of more than 654.38+0.4 billion yuan. Providing more than18,000 jobs for the society, including more than 8,000 laid-off workers.

Third, the honor won.

Since 2000, it has been ranked first in the comprehensive ranking of pharmaceutical enterprises in Jilin Province for six consecutive years, and ranked first in the profit of pharmaceutical enterprises in China in 2004. It is a leading pharmaceutical enterprise in Jilin Province and a large taxpayer in private enterprises. It has successively won dozens of honors, such as national contract-abiding enterprises, national honest and law-abiding township enterprises, national torch plan key high-tech enterprises, national scientific and technological innovation spark leading enterprises, outstanding enterprises in Jilin Province, and advanced units in spiritual civilization construction in Jilin Province.

The Group has continuously deepened the reform, innovated and changed, established and improved the modern enterprise system, and formed a brand-new concept and model for the leadership system and management mechanism. The Group has always been full of vigor and vitality, and has stepped into the track of sustainable development with extraordinary speed, steady operation and impressive performance.